tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robbie Marcus, 188 are a BUY (61.44%), 99 are a HOLD (32.35%), 19 are a SELL (6.21%).
Analyst Robbie Marcus, currently employed at JPMORGAN, carries an average stock price target met ratio of 61.01% that have a potential upside of 19.16% achieved within 163 days.
Robbie Marcus’s has documented 599 price targets and ratings displayed on 38 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IART, Integra LifeSciences Holdings.
Analyst best performing recommendations are on RXST (RXSIGHT).
The best stock recommendation documented was for INGN (INOGEN) at 5/8/2019. The price target of $72 was fulfilled within 1 day with a profit of $4.21 (6.21%) receiving and performance score of 62.1.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$0.74
$0.52 (236.36%)
$1
3 years 2 months 18 days ago
(08-Aug-2023)
5/8 (62.5%)
$0.1 (15.63%)
61
Hold
$1.5
$1.28 (581.82%)
4 years 2 months 10 days ago
(16-Aug-2022)
1/2 (50%)
$0.05 (3.45%)
2
Buy
$1.5
$1.28 (581.82%)
4 years 4 months 2 days ago
(24-Jun-2022)
1/5 (20%)
$0.96 (177.78%)
27
Sell
$19
4 years 11 months 14 days ago
(12-Nov-2021)
0/2 (0%)
$3.71 (16.84%)
Hold
$23
$21.36 (1302.44%)
$30
5 years 7 months 6 days ago
(19-Mar-2021)
0/3 (0%)
$4.37 (22.18%)
Which stock is Robbie Marcus most bullish on?
Which stock is Robbie Marcus most reserved on?
What Year was the first public recommendation made by Robbie Marcus?
